If you liked this article you might like

Drugmakers Plan Big Deals in 2017 -- and Banks Will Collect Big Fees
Laser-Maker Cynosure Leads Biotech Movers Ahead of Market Open
Biotech School: When Cellceutix CEO Rants About 'Criminal' Short, Smart Investors See Red Flags
Allergan, Apple, Facebook: Doug Kass' Views